Investment
Features
FeesSafety
Academy
More
Pluang+

Corteva and Inari settle 2023 seed patent lawsuit with confidential terms and licensing talks.

Market News
28 Sep 2026
PRNewsWire
View Source
Neutral
Corteva and Inari settle 2023 seed patent lawsuit with confidential terms and licensing talks.

Corteva and Inari have reached a confidential settlement to resolve a 2023 lawsuit over seed patent issues. Inari agreed to destroy certain Corteva materials and assign related intellectual property back to Corteva. Both companies will negotiate licensing agreements as part of the deal. This settlement highlights the importance of patent protections and legal compliance in agricultural innovation.

The settlement agreement between Corteva and Inari provides context for readers interested in corporate legal resolutions. For readers following the broader US stock market on Pluang as of Sep 28, 2026 23:13 WIB, out of 150 priced US stocks, 35 rose and 115 fell. Notable movers include QUALCOMM (QCOM) at USD 189.79 with a 1-day change of -5.98% and a typical hold time of 88 days, Boeing (BA) at USD 187.92 down 5.12%, and Kinross Gold Corporation (KGC) at USD 23.95 down 4.39%.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
1 hour ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
2 hours ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
2 hours ago
10x Genomics gets Buy rating despite insider selling and valuation concerns.

10x Genomics gets Buy rating despite insider selling and valuation concerns.

Argus Research initiated coverage on 10x Genomics with a Buy rating and a $110 price target, suggesting a 28% upside from its current price of around $85. The stock shows strong momentum, trading well above its 50-day and 200-day moving averages. How...

Analyst Insights
Neutral
3 hours ago
Morgan Stanley upgrades Cullen/Frost Bankers with strong institutional buying and a $201 price target.

Morgan Stanley upgrades Cullen/Frost Bankers with strong institutional buying and a $201 price target.

Morgan Stanley reaffirmed an "Overweight" rating on Cullen/Frost Bankers, Inc., raising its price target to $201, signaling confidence in the bank's prospects. Major institutional investors like State Street Corp and BlackRock have increased or initi...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App